-
1
-
-
84884597711
-
-
Centers for Disease Control and Prevention, (accessed 13 November 2013)
-
Centers for Disease Control and Prevention (2013) Antibiotic resistance threats in the United States, 2013. www.cdc.gov/drugresistance/threat-report- 2013/ (accessed 13 November 2013)
-
(2013)
Antibiotic Resistance Threats in the United States, 2013
-
-
-
2
-
-
84902008936
-
-
Department of Health, (accessed 23 November 2013)
-
Department of Health (2012) ESBLs: A Threat to Human and Animal Health. https://www.gov.uk/government/publications/esbls-a-threat-to-human-and-animal- health (accessed 23 November 2013)
-
(2012)
ESBLs: A Threat to Human and Animal Health
-
-
-
3
-
-
84892458585
-
-
Department of Health, (accessed 13 November 2013)
-
Department of Health (2013) Chief Medical Officer annual report: volume 2. www.gov.uk/government/ publications/chief-medical-officer-annual-report- volume-2 (accessed 13 November 2013)
-
(2013)
Chief Medical Officer Annual Report
, vol.2
-
-
-
4
-
-
38849113780
-
Market failure and the poverty of new drugs in maternal health
-
doi:10.1371/journal. pmed.0050022)
-
Fisk NM, Atun R (2008) Market Failure and the Poverty of New Drugs in Maternal Health. PLoS Medicine 5(1): e22 (doi:10.1371/journal. pmed.0050022)
-
(2008)
PLoS Medicine
, vol.5
, Issue.1
-
-
Fisk, N.M.1
Atun, R.2
-
5
-
-
84878488692
-
Public-private partnerships as driving forces in the quest for innovative medicines
-
doi: 10.1186/2001-1326-2-2
-
Goldman M, Compton C, Mittleman BB (2013) Public-private partnerships as driving forces in the quest for innovative medicines. Clin Transl Med 2(1): 2 (doi: 10.1186/2001-1326-2-2)
-
(2013)
Clin Transl Med
, vol.2
, Issue.1
, pp. 2
-
-
Goldman, M.1
Compton, C.2
Mittleman, B.B.3
-
6
-
-
84892464729
-
Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010
-
(Epub ahead of print) (doi: 10.1093/jac/ dkt349)
-
Head MG, Fitchett JR, Cooke MK et al (2013a) Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010. J Antimicrob Chemother Sep 13 (Epub ahead of print) (doi: 10.1093/jac/ dkt349)
-
(2013)
J Antimicrob Chemother Sep
, vol.13
-
-
Head, M.G.1
Fitchett, J.R.2
Cooke, M.K.3
-
7
-
-
84871052731
-
UK investments in global infectious disease research 1997-2010: A case study
-
doi: 10.1016/S1473-3099(12)70261-X)
-
Head MG, Fitchett JR, Cooke MK, Wurie FB, Hayward AC, Atun R (2013b) UK investments in global infectious disease research 1997-2010: a case study. Lancet Infect Dis 13(1): 55-64 (doi: 10.1016/S1473-3099(12)70261-X)
-
(2013)
Lancet Infect Dis
, vol.13
, Issue.1
, pp. 55-64
-
-
Head, M.G.1
Fitchett, J.R.2
Cooke, M.K.3
Wurie, F.B.4
Hayward, A.C.5
Atun, R.6
-
9
-
-
84901987571
-
-
National Institute for Health Research, (accessed 14 October 2013)
-
National Institute for Health Research (2013) Antimicrobial Resistance Themed Call. www.themedcalls.nihr.ac.uk/amr (accessed 14 October 2013)
-
(2013)
Antimicrobial Resistance Themed Call
-
-
|